{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:40:32Z","timestamp":1778154032658,"version":"3.51.4"},"reference-count":117,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["Aspasia-NWO 015.015.040"],"award-info":[{"award-number":["Aspasia-NWO 015.015.040"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The SARS-CoV-2 pandemic has urged the development of protective vaccines and the search for specific antiviral drugs. The modern molecular biology tools provides alternative methods, such as CRISPR-Cas and RNA interference, that can be adapted as antiviral approaches, and contribute to this search. The unique CRISPR-Cas13d system, with the small crRNA guide molecule, mediates a sequence-specific attack on RNA, and can be developed as an anti-coronavirus strategy. We analyzed the SARS-CoV-2 genome to localize the hypothetically best crRNA-annealing sites of 23 nucleotides based on our extensive expertise with sequence-specific antiviral strategies. We considered target sites of which the sequence is well-conserved among SARS-CoV-2 isolates. As we should prepare for a potential future outbreak of related viruses, we screened for targets that are conserved between SARS-CoV-2 and SARS-CoV. To further broaden the search, we screened for targets that are conserved between SARS-CoV-2 and the more distantly related MERS-CoV, as well as the four other human coronaviruses (OC43, 229E, NL63, HKU1). Finally, we performed a search for pan-corona target sequences that are conserved among all these coronaviruses, including the new Omicron variant, that are able to replicate in humans. This survey may contribute to the design of effective, safe, and escape-proof antiviral strategies to prepare for future pandemics.<\/jats:p>","DOI":"10.3390\/v14020385","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T20:58:03Z","timestamp":1644872283000},"page":"385","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack"],"prefix":"10.3390","volume":"14","author":[{"given":"Mouraya","family":"Hussein","sequence":"first","affiliation":[{"name":"Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaria","family":"Andrade dos Ramos","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Berkhout","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9986-8552","authenticated-orcid":false,"given":"Elena","family":"Herrera-Carrillo","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam University Medical Centers, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/CM9.0000000000000722","article-title":"Identification of a novel coronavirus causing severe pneumonia in human: A descriptive study","volume":"133","author":"Ren","year":"2020","journal-title":"Chin. Med. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.1087139","article-title":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China","volume":"302","author":"Guan","year":"2003","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm1024","article-title":"Identification of a new human coronavirus","volume":"10","author":"Pyrc","year":"2004","journal-title":"Nat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1073\/pnas.57.4.933","article-title":"Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease","volume":"57","author":"McIntosh","year":"1967","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3181\/00379727-121-30734","article-title":"A new virus isolated from the human respiratory tract","volume":"121","author":"Hamre","year":"1966","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3201\/eid1509.090224","article-title":"Distant Relatives of Severe Acute Respiratory Syndrome Coronavirus and Close Relatives of Human Coronavirus 229E in Bats, Ghana","volume":"15","author":"Pfefferle","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12816","DOI":"10.1128\/JVI.00906-12","article-title":"Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63","volume":"86","author":"Huynh","year":"2012","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"13004","DOI":"10.1128\/JVI.01255-10","article-title":"Metagenomic Analysis of the Viromes of Three North American Bat Species: Viral Diversity among Different Bat Species That Share a Common Habitat","volume":"84","author":"Donaldson","year":"2010","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3201\/eid1205.051316","article-title":"Coronavirus HKU1 infection in the United States","volume":"12","author":"Esper","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcv.2006.12.008","article-title":"Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients","volume":"38","author":"Gerna","year":"2007","journal-title":"J. Clin. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1021\/acsinfecdis.0c00874","article-title":"Early Returns on Small Molecule Therapeutics for SARS-CoV-2","volume":"7","author":"Namchuk","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"111313","DOI":"10.1016\/j.biopha.2021.111313","article-title":"An update review of emerging small-molecule therapeutic options for COVID-19","volume":"137","author":"Tian","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41594-021-00653-y","article-title":"Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome","volume":"28","author":"Zhang","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"111363","DOI":"10.1016\/j.biopha.2021.111363","article-title":"Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity","volume":"137","author":"Mehrabadi","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e2023051118","DOI":"10.1073\/pnas.2023051118","article-title":"Restriction of SARS-CoV-2 replication by targeting programmed-1 ribosomal frameshifting","volume":"118","author":"Sun","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ymthe.2006.07.007","article-title":"Silencing of HIV-1 with RNA interference: A multiple shRNA approach","volume":"14","author":"Konstantinova","year":"2006","journal-title":"Mol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/oli.2006.0069","article-title":"shRNAs targeting hepatitis C: Effects of sequence and structural features, and comparision with siRNA","volume":"17","author":"Vlassov","year":"2007","journal-title":"Oligonucleotides"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/ng1650","article-title":"Second-generation shRNA libraries covering the mouse and human genomes","volume":"37","author":"Silva","year":"2005","journal-title":"Nat. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/gt.2017.44","article-title":"Silencing of HIV-1 by AgoshRNA molecules","volume":"24","author":"Harwig","year":"2017","journal-title":"Gene Ther."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Herrera-Carrillo, E., and Berkhout, B. (2017). Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177935"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1099\/mic.0.023960-0","article-title":"Short motif sequences determine the targets of the prokaryotic CRISPR defence system","volume":"155","author":"Mojica","year":"2009","journal-title":"Microbiology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature09523","article-title":"The CRISPR\/Cas bacterial immune system cleaves bacteriophage and plasmid DNA","volume":"468","author":"Garneau","year":"2010","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1093\/nar\/gkaa226","article-title":"Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA","volume":"48","author":"Gao","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.celrep.2016.11.057","article-title":"A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures","volume":"17","author":"Wang","year":"2016","journal-title":"Cell Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41421-018-0069-3","article-title":"Repurposing CRISPR-Cas12b for mammalian genome engineering","volume":"4","author":"Teng","year":"2018","journal-title":"Cell Discov."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"aaf5573","DOI":"10.1126\/science.aaf5573","article-title":"C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector","volume":"353","author":"Abudayyeh","year":"2016","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1038\/s41467-019-10507-3","article-title":"Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.molcel.2018.02.028","article-title":"Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein","volume":"70","author":"Yan","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13059-019-1881-2","article-title":"CRISPR-Cas13d mediates robust RNA virus interference in plants","volume":"20","author":"Mahas","year":"2019","journal-title":"Genome Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s13238-020-00700-2","article-title":"Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver","volume":"11","author":"He","year":"2020","journal-title":"Protein Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1128\/JVI.02501-05","article-title":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex","volume":"80","author":"Snijder","year":"2006","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"10515","DOI":"10.1128\/JVI.77.19.10515-10527.2003","article-title":"Characterization of the expression, intracellular localization, and replication complex association of the putative mouse hepatitis virus RNA-dependent RNA polymerase","volume":"77","author":"Brockway","year":"2003","journal-title":"J. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3527(08)60286-9","article-title":"The molecular biology of coronaviruses","volume":"48","author":"Lai","year":"1997","journal-title":"Adv. Virus Res."},{"key":"ref_46","unstructured":"Vandermost, R.G., Degroot, R.J., Luytjes, W., and Spaan, W.J.M. (1993). Coronavirus Di Rnas\u2014A Tool to Study Replication, Transcription and Recombination. J. Cell. Biochem., 4. Available online: https:\/\/www.webofscience.com\/wos\/woscc\/full-record\/WOS:A1993KV88000007?SID=D5lW7lNpPiN6pZxbFOX."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cell.2018.09.001","article-title":"Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d","volume":"175","author":"Zhang","year":"2018","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1097\/QAD.0b013e328309efe3","article-title":"Probing the sequence space available for HIV-1 evolution","volume":"22","author":"Berkhout","year":"2008","journal-title":"AIDS"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: Improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol. Biol. Evol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nature24049","article-title":"RNA targeting with CRISPR-Cas13","volume":"550","author":"Abudayyeh","year":"2017","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41587-020-0456-9","article-title":"Massively parallel Cas13 screens reveal principles for guide RNA design","volume":"38","author":"Wessels","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/jtbi.1997.0493","article-title":"Estimating the entropy of DNA sequences","volume":"188","author":"Schmitt","year":"1997","journal-title":"J. Theor. Biol."},{"key":"ref_53","first-page":"306","article-title":"The mathematical theory of communication. 1963","volume":"14","author":"Shannon","year":"1997","journal-title":"MD Comput."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"W135","DOI":"10.1093\/nar\/gkh449","article-title":"Sfold web server for statistical folding and rational design of nucleic acids","volume":"32","author":"Ding","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_55","first-page":"201","article-title":"Guidelines for the selection of effective short-interfering RNA sequences for functional genomics","volume":"361","author":"Naito","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1093\/nar\/gks797","article-title":"siSPOTR: A tool for designing highly specific and potent siRNAs for human and mouse","volume":"41","author":"Boudreau","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Pan, W.J., Chen, C.W., and Chu, Y.W. (2011). siPRED: Predicting siRNA efficacy using various characteristic methods. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027602"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1261\/rna.546207","article-title":"Effect of target secondary structure on RNAi efficiency","volume":"13","author":"Shao","year":"2007","journal-title":"RNA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nbt936","article-title":"Rational siRNA design for RNA interference","volume":"22","author":"Reynolds","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0092-8674(02)00908-X","article-title":"Single-stranded antisense siRNAs guide target RNA cleavage in RNAi","volume":"110","author":"Martinez","year":"2002","journal-title":"Cell"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1261\/rna.043950.113","article-title":"Probing the shRNA characteristics that hinder Dicer recognition and consequently allow Ago-mediated processing and AgoshRNA activity","volume":"20","author":"Harwig","year":"2014","journal-title":"RNA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1093\/nar\/gkt036","article-title":"Dicer-independent processing of short hairpin RNAs","volume":"41","author":"Liu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1099\/0022-1317-82-2-385","article-title":"The RNA structures engaged in replication and transcription of the A59 strain of mouse hepatitis virus","volume":"82","author":"Sawicki","year":"2001","journal-title":"J. Gen. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/gt.2015.11","article-title":"The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy","volume":"22","author":"Berkhout","year":"2015","journal-title":"Gene Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-4939-2432-5_4","article-title":"Gene therapy strategies to block HIV-1 replication by RNA interference","volume":"848","author":"Berkhout","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/mt.2012.107","article-title":"Inhibition of Hepatitis C Virus Replication by Intracellular Delivery of Multiple siRNAs by Nanosomes","volume":"20","author":"Chandra","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12192-016-0747-8","article-title":"Inhibition of hepatitis C virus using siRNA targeted to the virus and Hsp90","volume":"22","author":"Braga","year":"2017","journal-title":"Cell Stress Chaperon"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1073\/pnas.252758799","article-title":"RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells","volume":"100","author":"Wilson","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2004.09.005","article-title":"Inhibition of SARS-CoV replication by siRNA","volume":"65","author":"Wu","year":"2005","journal-title":"Antivir. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-5793(04)00087-0","article-title":"Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference","volume":"560","author":"Zhang","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.gt.3302479","article-title":"siRNA targeting the leader sequence of SARS-CoV inhibits virus replication","volume":"12","author":"Li","year":"2005","journal-title":"Gene Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nmeth911","article-title":"On the art of identifying effective and specific siRNAs","volume":"3","author":"Pei","year":"2006","journal-title":"Nat. Methods"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.1093\/nar\/gkx779","article-title":"Dicer-independent processing of small RNA duplexes: Mechanistic insights and applications","volume":"45","author":"Berkhout","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_74","unstructured":"U.S. Food & Drug Administration (2021, December 07). FDA Approves First Treatment for COVID-19, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-Covid-19."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.molcel.2019.09.013","article-title":"Programmable Inhibition and Detection of RNA Viruses Using Cas13","volume":"76","author":"Freije","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41587-021-00822-w","article-title":"Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents","volume":"39","author":"Blanchard","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-907X-2-8","article-title":"The dose can make the poison: Lessons learned from adverse in vivo toxicities caused by RNAi overexpression","volume":"2","author":"Grimm","year":"2011","journal-title":"Silence"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1042\/BST20160060","article-title":"Attacking HIV-1 RNA versus DNA by sequence-specific approaches: RNAi versus CRISPR-Cas","volume":"44","author":"Berkhout","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/mt.2016.24","article-title":"CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape","volume":"24","author":"Wang","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1093\/nar\/gkm437","article-title":"A systematic analysis of the effect of target RNA structure on RNA interference","volume":"35","author":"Westerhout","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3181\/0903-MR-94","article-title":"Coronavirus diversity, phylogeny and interspecies jumping","volume":"234","author":"Woo","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/jvi.57.3.729-737.1986","article-title":"High-frequency RNA recombination of murine coronaviruses","volume":"57","author":"Makino","year":"1986","journal-title":"J. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1177\/0300985820943535","article-title":"Clinical and Pathological Findings in SARS-CoV-2 Disease Outbreaks in Farmed Mink (Neovison vison)","volume":"57","author":"Molenaar","year":"2020","journal-title":"Vet. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(20)30912-9","article-title":"SARS-CoV-2 and the human-animal interface: Outbreaks on mink farms","volume":"21","author":"Koopmans","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Boklund, A., Hammer, A.S., Quaade, M.L., Rasmussen, T.B., Lohse, L., Strandbygaard, B., Jorgensen, C.S., Olesen, A.S., Hjerpe, F.B., and Petersen, H.H. (2021). SARS-CoV-2 in Danish Mink Farms: Course of the Epidemic and a Descriptive Analysis of the Outbreaks in 2020. Animals, 11.","DOI":"10.3390\/ani11010164"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/JVI.01358-06","article-title":"A contemporary view of coronavirus transcription","volume":"81","author":"Sawicki","year":"2007","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7150\/thno.51479","article-title":"Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygeno.2020.12.021","article-title":"A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2","volume":"113","author":"Chowdhury","year":"2021","journal-title":"Genomics"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Gao, S.J., Guo, H., and Luo, G. (2021). Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert!. J. Med. Virol., 1\u20132.","DOI":"10.1002\/jmv.27491"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1002\/ctm2.685","article-title":"The omicron variant of SARS-CoV-2: Understanding the known and living with unknowns","volume":"11","author":"Ingraham","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"102779","DOI":"10.1016\/j.jaut.2021.102779","article-title":"Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies","volume":"126","author":"Kannan","year":"2022","journal-title":"J. Autoimmun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"830527","DOI":"10.3389\/fimmu.2021.830527","article-title":"Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies","volume":"12","author":"Shah","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Wilhelm, A., Widera, M., Grikscheit, K., Toptan, T., Schenk, B., Pallas, C., Metzler, M., Kohmer, N., Hoehl, S., and Helfritz, F.A. (2021). Reduced neutralization of SARS-CoV-2 omicron variant by vaccine Sera and monoclonal antibodies. MedRxiv, 1\u20139.","DOI":"10.1101\/2021.12.07.21267432"},{"key":"ref_96","unstructured":"U.S. Food & Drug Administration (2021, December 20). Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jmii.2021.03.007","article-title":"Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells","volume":"54","author":"Wu","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Ko, M., Chang, S.Y., Byun, S.Y., Ianevski, A., Choi, I., Pham Hung d\u2019Alexandry d\u2019Orengiani, A.-L., Ravlo, E., Wang, W., Bj\u00f8r\u00e5s, M., and Kainov, D.E. (2021). Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19. Viruses, 13.","DOI":"10.3390\/v13040651"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"104974","DOI":"10.1016\/j.antiviral.2020.104974","article-title":"A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2","volume":"185","author":"Zhang","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"10900","DOI":"10.1128\/JVI.00385-06","article-title":"Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis","volume":"80","author":"Almazan","year":"2006","journal-title":"J. Virol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., and Madden, T.L. (2009). BLAST+: Architecture and applications. BMC Bioinform., 10.","DOI":"10.1186\/1471-2105-10-421"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/nar\/gki324","article-title":"A computational study of off-target effects of RNA interference","volume":"33","author":"Qiu","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2018.02.033","article-title":"Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors","volume":"173","author":"Konermann","year":"2018","journal-title":"Cell"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nbt831","article-title":"Expression profiling reveals off-target gene regulation by RNAi","volume":"21","author":"Jackson","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/gt.2011.191","article-title":"A competitive cell growth assay for the detection of subtle effects of gene transduction on cell proliferation","volume":"19","author":"Eekels","year":"2012","journal-title":"Gene Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1038\/s41467-020-17796-z","article-title":"Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells","volume":"11","author":"Zhu","year":"2020","journal-title":"Nat Commun."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1134\/S1068162019060025","article-title":"Systems of Delivery of CRISPR\/Cas9 Ribonucleoprotein Complexes for Genome Editing","volume":"45","author":"Amirkhanov","year":"2019","journal-title":"Russ. J. Bioorg. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1038\/s41467-019-12922-y","article-title":"Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia","volume":"10","author":"Krishnamurthy","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acs.accounts.9b00106","article-title":"Delivery Aspects of CRISPR\/Cas for in Vivo Genome Editing","volume":"52","author":"Wilbie","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2019.11.005","article-title":"Rational designs of in vivo CRISPR-Cas delivery systems","volume":"168","author":"Xu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.addr.2020.06.001","article-title":"Inhalation delivery technology for genome-editing of respiratory diseases","volume":"168","author":"Chow","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Chan, K.G., Ang, G.Y., Yu, C.Y., and Yean, C.Y. (2021). Harnessing CRISPR-Cas to combat COVID-19: From diagnostics to therapeutics. Life, 11.","DOI":"10.3390\/life11111210"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Guaman-Bautista, L.P., Moreta-Urbano, E., O\u00f1a-Arias, C.G., Torres-Arias, M., Kyriakidis, N.C., Malc\u0131, K., Jonguitud-Borrego, N., Rios-Solis, L., Ramos-Martinez, E., and L\u00f3pez-Cort\u00e9s, A. (2021). Tracking SARS-CoV-2: Novel trends and diagnostic strategies. Diagnostics, 11.","DOI":"10.3390\/diagnostics11111981"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e00745-20","DOI":"10.1128\/JCM.00745-20","article-title":"Sherlock and DETECTR: CRISPR-CAS systems as potential rapid diagnostic tools for emerging infectious diseases","volume":"59","author":"Mustafa","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_116","unstructured":"(2022, January 02). Sherlock Biosciences Receives FDA Emergency Use Authorization for CRISPR SARS-CoV-2 Rapid Diagnostic. Available online: https:\/\/sherlock.bio\/sherlock-biosciences-receives-fda-emergency-use-authorization-for-crispr-sars-cov-2-rapid-diagnostic\/."},{"key":"ref_117","unstructured":"(2022, January 02). SARS-CoV-2 RNA DETECTR Assay, Available online: https:\/\/www.fda.gov\/media\/139937\/download."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/2\/385\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:19:12Z","timestamp":1760134752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/2\/385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":117,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["v14020385"],"URL":"https:\/\/doi.org\/10.3390\/v14020385","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]}}}